Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea

PURPOSE: To investigate whether clinically relevant levels of epigallocatechin gallate (EGCG, a component of green tea) or vitamin C (ascorbic acid) could antagonize bortezomib antitumor activity in CWR22 human prostate xenograft tumors. METHODS: The pharmacokinetics (PK) of EGCG and ascorbic acid w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bannerman, Bret, Xu, Ling, Jones, Matthew, Tsu, Christopher, Yu, Jie, Hales, Paul, Monbaliu, Johan, Fleming, Paul, Dick, Lawrence, Manfredi, Mark, Claiborne, Christopher, Bolen, Joseph, Kupperman, Erik, Berger, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215871/
https://www.ncbi.nlm.nih.gov/pubmed/21400028
http://dx.doi.org/10.1007/s00280-011-1591-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215871/
https://www.ncbi.nlm.nih.gov/pubmed/21400028
http://dx.doi.org/10.1007/s00280-011-1591-2

Ejemplares similares